Westfield Capital Management CO LP Invitae Corp Transaction History

Westfield Capital Management CO LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.28 - $15.59 $6.09 Million - $15.1 Million	-970,218 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$14.7 - $28.67 $4.93 Million - $9.62 Million	-335,463 Reduced 25.69%	970,218 $14.8 Million
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $6.69 Million - $9.24 Million	275,005 Added 26.68%	1,305,681 $37.1 Million
Q2 2021 Aug 10, 2021	BUY	$26.09 - $40.4 $3.9 Million - $6.05 Million	149,641 Added 16.98%	1,030,676 $34.8 Million
Q1 2021 May 14, 2021	BUY	$33.06 - $56.93 $29.1 Million - $50.2 Million	881,035 New	881,035 $33.7 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

Stay updated on Westfield Capital Management CO LP with notifications on news.